Evidence map›Paper›PMID 33150486›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2021

Histologic Analysis of Testes from Prepubertal Patients Treated with Chemotherapy Associates Impaired Germ Cell Counts with Cumulative Doses of Cyclophosphamide, Ifosfamide, Cytarabine, and Asparaginase.

Jose V Medrano, D Hervás, T Vilanova-Pérez, A Navarro-Gomezlechon, E Goossens, A Pellicer, M M Andrés, E Novella-Maestre

Open access · bronzeAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Testicular Stem Cells Survive Oncotherapy.Reproductive sciences (Thousand Oaks, Calif.) · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jose V MedranoInstituto de Investigación Sanitaria La Fe (IIS La Fe), Av. Fernando Abril Martorell, 106. Tower A, Lab. 6.22, 46026, Valencia, Spain. jomepla@gmail.com.ORCID 0000-0002-7616-1375
D HervásInstituto de Investigación Sanitaria La Fe (IIS La Fe), Av. Fernando Abril Martorell, 106. Tower A, Lab. 6.22, 46026, Valencia, Spain.
T Vilanova-PérezInstituto de Investigación Sanitaria La Fe (IIS La Fe), Av. Fernando Abril Martorell, 106. Tower A, Lab. 6.22, 46026, Valencia, Spain.
A Navarro-GomezlechonInstituto de Investigación Sanitaria La Fe (IIS La Fe), Av. Fernando Abril Martorell, 106. Tower A, Lab. 6.22, 46026, Valencia, Spain.
E GoossensVrije Universiteit Brussel (VUB), 1090, Brussels, Belgium.
A PellicerInstituto de Investigación Sanitaria La Fe (IIS La Fe), Av. Fernando Abril Martorell, 106. Tower A, Lab. 6.22, 46026, Valencia, Spain.
M M AndrésInstituto de Investigación Sanitaria La Fe (IIS La Fe), Av. Fernando Abril Martorell, 106. Tower A, Lab. 6.22, 46026, Valencia, Spain.
E Novella-MaestreInstituto de Investigación Sanitaria La Fe (IIS La Fe), Av. Fernando Abril Martorell, 106. Tower A, Lab. 6.22, 46026, Valencia, Spain.
Instituto de Investigación Sanitaria La Fe · ESHospital Universitari i Politècnic La Fe · ESValencian Infertility Institute · ESVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryopreservation of immature testicular tissue is an experimental strategy for the preservation of fertility in prepubertal boys that will be subjected to a gonadotoxic onset, as is the case of oncologic patients. Therefore, the objective of this study was to assess the impact of chemotherapeutic treatments on the testicular histologic phenotype in prepubertal patients. A total of 56 testicular tissue samples from pediatric patients between 0 and 16 years old (28 with at least one previous chemotherapeutic onset and 28 untreated controls) were histologically analyzed and age-matched compared. At least two 5-μm sections from testis per patient separated by a distance of 100 μm were immunostained for the germ cell marker VASA, the spermatogonial markers UTF1, PLZF, UCHL1, and SALL4, the marker for proliferative cells KI67, and the Sertoli cell marker SOX9. The percentage of tubule cross-sections positive for each marker and the number of positive cells per tubule cross-section were determined and association with the cumulative dose received of each chemotherapeutic drug was statistically assessed. Results indicated that alkylating agents, cyclophosphamide and ifosfamide, but also the antimetabolite cytarabine and asparaginase were associated with a decreased percentage of positive tubules and a lower number of positive cells per tubule for the analyzed markers. Our results provide new evidences of the potential of chemotherapeutic agents previously considered to have low gonadotoxic effects such as cytarabine and asparaginase to trigger a severe testicular phenotype, hampering the potential success of future fertility restoration in experimental programs of fertility preservation in prepubertal boys.

Indexed as

AdolescentAge FactorsAntineoplastic AgentsAsparaginaseBelgiumCase-Control StudiesChildChild, PreschoolCyclophosphamideCytarabineDEAD-box RNA HelicasesFertilityFertility PreservationHumansIfosfamideInfertility, MaleAntineoplastic AgentsAsparaginaseCyclophosphamideCytarabineDDX4 protein, humanDEAD-box RNA HelicasesIfosfamideKi-67 AntigenMKI67 protein, humanNuclear ProteinsPromyelocytic Leukemia Zinc Finger ProteinSALL4 protein, humanSOX9 protein, humanSOX9 Transcription FactorTrans-ActivatorsTranscription FactorsUbiquitin ThiolesteraseUCHL1 protein, humanUTF1 protein, humanZBTB16 protein, humanChemotherapyFertility preservationGonadotoxicityPrepubertal patientsTesticular tissue

Identifiers

PMID33150486
OpenAlexW3095543962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.